TABLE 3.

Antimicrobial susceptibility pattern of novel group of isolates

Antimicrobial agentMIC (μg/ml)a for strain:
4773W55W58283416Va2
Ciprofloxacin>16 (r)4 (r)>16 (r)8 (r)16 (r)
Clarithromycin0.25 (s)0.25 (s)4 (s)2 (s)4 (s)
Ethambutol8 (r)4 (s)16 (r)>16 (r)>16 (r)
Gatifloxacin8 (r)4 (i)8 (r)1 (s)4 (i)
Isoniazid1 (s)2 (s)4 (s)>16 (r)8 (r)
Minocycline>16 (r)16 (r)>16 (r)>16 (r)>16 (r)
Moxifloxacin1 (s)2 (i)2 (i)1 (s)1 (s)
Rifabutin≤0.12 (s)≤0.12 (s)0.5 (s)0.25 (s)0.25 (s)
Rifampin4 (r)4 (r)32 (r)8 (r)32 (r)
Sulfamethoxazole32 (s)16 (s)16 (s)32 (s)32 (s)
  • a r, resistant; s, susceptible, i, intermediate.